Literature DB >> 9151780

G-protein-coupled receptor kinase activity is increased in hypertension.

R Gros1, J L Benovic, C M Tan, R D Feldman.   

Abstract

Impaired vascular beta-adrenergic responsiveness may play an important role in the development and/or maintenance of hypertension. This defect has been associated with an alteration in receptor/guanine nucleotide regulatory protein (G-protein) interactions. However, the locus of this defect remains unclear. G-Protein-coupled receptor kinases (GRKs) phosphorylate serine/threonine residues on G-protein-linked receptors in an agonist-dependent manner. GRK activation mediates reduced receptor responsiveness and impaired receptor/G-protein coupling. To determine whether the impairment in beta-adrenergic response in human hypertension might be associated with altered GRK activity, we studied lymphocytes from younger hypertensive subjects as compared with older and younger normotensive subjects. We assessed GRK activity by rhodopsin phosphorylation and GRK expression by immunoblot. GRK activity was significantly increased in lymphocytes from younger hypertensive subjects and paralleled an increase in GRK-2 (beta ARK-1) protein expression. In contrast, no alterations in cAMP-dependent kinase (A-kinase) activity or GRK-5/6 expression were noted. GRK activity was not increased in lymphocytes from older normotensive subjects who demonstrated a similar impairment in beta-adrenergic-mediated adenylyl cyclase activation. These studies indicate that GRK activity is selectively increased in lymphocytes from hypertensive subjects. The increase in GRK activity may underlie the reduction in beta-adrenergic responsiveness characteristic of the hypertensive state.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151780      PMCID: PMC508038          DOI: 10.1172/JCI119381

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  A low-sodium diet corrects the defect in beta-adrenergic response in older subjects.

Authors:  R D Feldman
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

2.  S-antigen: preparation and characterization of site-specific monoclonal antibodies.

Authors:  L A Donoso; D S Gregerson; L Smith; S Robertson; V Knospe; T Vrabec; C M Kalsow
Journal:  Curr Eye Res       Date:  1990-04       Impact factor: 2.424

Review 3.  Adrenergic receptor responsiveness and congestive heart failure.

Authors:  G L Stiles
Journal:  Am J Cardiol       Date:  1991-05-06       Impact factor: 2.778

Review 4.  Role of phosphorylation in desensitization of the beta-adrenoceptor.

Authors:  R J Lefkowitz; W P Hausdorff; M G Caron
Journal:  Trends Pharmacol Sci       Date:  1990-05       Impact factor: 14.819

Review 5.  Turning off the signal: desensitization of beta-adrenergic receptor function.

Authors:  W P Hausdorff; M G Caron; R J Lefkowitz
Journal:  FASEB J       Date:  1990-08       Impact factor: 5.191

6.  Overexpression of beta-arrestin and beta-adrenergic receptor kinase augment desensitization of beta 2-adrenergic receptors.

Authors:  S Pippig; S Andexinger; K Daniel; M Puzicha; M G Caron; R J Lefkowitz; M J Lohse
Journal:  J Biol Chem       Date:  1993-02-15       Impact factor: 5.157

7.  Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet.

Authors:  R D Feldman
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

8.  Low sodium intake corrects abnormality in beta-receptor-mediated arterial vasodilation in patients with hypertension: correlation with beta-receptor function in vitro.

Authors:  T Naslund; D J Silberstein; W J Merrell; J H Nadeau; A J Wood
Journal:  Clin Pharmacol Ther       Date:  1990-07       Impact factor: 6.875

9.  Proliferative response of T lymphocytes to mitogenic lectins in essential hypertension.

Authors:  S M Shasha; U Shasha; B Kristal; M Barzilai; O Steinberger; T Shkolnik
Journal:  Nephron       Date:  1991       Impact factor: 2.847

10.  Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

Authors:  M Ungerer; M Böhm; J S Elce; E Erdmann; M J Lohse
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

View more
  64 in total

Review 1.  Exploring the dynamics of regulation of G protein-coupled receptors using green fluorescent protein.

Authors:  G Milligan
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

2.  Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction.

Authors:  D C White; J A Hata; A S Shah; D D Glower; R J Lefkowitz; W J Koch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 3.  β-Adrenergic receptor subtype signaling in heart: from bench to bedside.

Authors:  Anthony Yiu Ho Woo; Rui-ping Xiao
Journal:  Acta Pharmacol Sin       Date:  2012-01-30       Impact factor: 6.150

4.  Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer.

Authors:  S A Akhter; C A Skaer; A P Kypson; P H McDonald; K C Peppel; D D Glower; R J Lefkowitz; W J Koch
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 5.  Mechanisms of regulation and function of G-protein-coupled receptor kinases.

Authors:  Wen Yang; Shi-Hai Xia
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

Review 6.  GRK mythology: G-protein receptor kinases in cardiovascular disease.

Authors:  Gerald W Dorn
Journal:  J Mol Med (Berl)       Date:  2009-02-20       Impact factor: 4.599

7.  Growth inhibition of human hepatocellular carcinoma cells by overexpression of G-protein-coupled receptor kinase 2.

Authors:  Zhengyu Wei; Reginald Hurtt; Michele Ciccarelli; Walter J Koch; Cataldo Doria
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

Review 8.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

Review 9.  Cardiovascular gene therapy for myocardial infarction.

Authors:  Maria C Scimia; Anna M Gumpert; Walter J Koch
Journal:  Expert Opin Biol Ther       Date:  2013-12-16       Impact factor: 4.388

Review 10.  G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms.

Authors:  Gaetano Santulli; Bruno Trimarco; Guido Iaccarino
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.